Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications

When diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a future clot.

Physical Activity in Older Adults; Oral Obesity Medication

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

July 9, 2023

CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S – Biotech Investments

CS MEDICA / Key word(s): IPO CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S 10-Jun-2024 / 14:06 CET/CEST Disclosure of an inside

June 11, 2024

ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer – Pharmaceutical Technology

In an interim readout of the Phase Ib/II Destiny-BREAST07 trial, the progression-free survival (PFS) at 12 months was 77.3% with Enhertu alone. Image credit: Shutterstock/tsyhun

June 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.